Literature DB >> 6125201

Control of blood pressure and reduction of echocardiographically assessed left ventricular mass with one-daily timolol.

D B Rowlands, D R Glover, T J Stallard, W A Littler.   

Abstract

1 Ten untreated hypertensive patients underwent 24 h continuous intra-arterial ambulatory monitoring of blood pressure (BP) and M-mode echocardiography. 2 They were treated with once-daily timolol and followed up at 2, 4, 8 and 12 weeks when dosage was titrated against BP control (indirect measurement) and degree of beta-adrenoceptor antagonism (submaximal bicycle ergometry and sub-lingual GTN). 3 Sixteen weeks after commencing therapy, nine patients underwent repeat continuous ambulatory monitoring of BP and M-mode echocardiography. 4 Casual BP was significantly reduced during the follow-up period at 2, 4, 8 and 12 weeks. 5 A reduction of BP was seen throughout the 24 h although this did not achieve statistical significance when sympathetic activity was low. 6 Echocardiographic measurement of left ventricular mass was significantly reduced after 16 weeks treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125201      PMCID: PMC1427577          DOI: 10.1111/j.1365-2125.1982.tb04939.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy.

Authors:  L E Teichholz; T Kreulen; M V Herman; R Gorlin
Journal:  Am J Cardiol       Date:  1976-01       Impact factor: 2.778

2.  Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.

Authors:  R B Devereux; N Reichek
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

3.  A new test of the degree of adrenergic beta receptor blockade.

Authors:  J D Fitzgerald
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1970-12

4.  Measurement of concentrations of angiotensin I in human blood by radioimmunoassay.

Authors:  M A Waite
Journal:  Clin Sci       Date:  1973-07       Impact factor: 6.124

5.  Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity.

Authors:  H S Smyth; P Sleight; G W Pickering
Journal:  Circ Res       Date:  1969-01       Impact factor: 17.367

6.  Hypertension--1974.

Authors:  J N Cohn
Journal:  Arch Intern Med       Date:  1974-06

7.  Continuous recording of direct arterial pressure and electrocardiogram in unrestricted man.

Authors:  W A Littler; A J Honour; P Sleight; F D Stott
Journal:  Br Med J       Date:  1972-07-08

8.  Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability.

Authors:  R D Watson; T J Stallard; W A Littler
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

9.  Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.

Authors:  A Scriabine; M L Torchiana; J M Stavorski; C T Ludden; D H Minsker; C A Stone
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-09

10.  Cardiac hypertrophy and antihypertensive therapy.

Authors:  S Sen; R C Tarazi; F M Bumpus
Journal:  Cardiovasc Res       Date:  1977-09       Impact factor: 10.787

View more
  10 in total

1.  Regression of left ventricular hypertrophy in "previously untreated" hypertensive blacks after 6 months of blood pressure reduction with alpha- and beta-adrenergic blockade and thiazide therapy.

Authors:  E Foster; J F Plehn; S A Bernard; N J Battinelli; M Huntington-Coats; C S Apstein
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

Review 2.  Therapeutic effect on left ventricular hypertrophy by different antihypertensive drugs.

Authors:  W Motz; B E Strauer
Journal:  Clin Investig       Date:  1992

3.  Comparison between the effects of urapidil and methyldopa on left ventricular hypertrophy and haemodynamics in humans.

Authors:  C A Feldstein; A O Olivieri; R P Sabarís
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension.

Authors:  M W Millar-Craig; S Mann; V Bala Subramanian; D G Altman; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Left ventricular mass changes with nicardipine therapy in essential hypertension.

Authors:  P Gosse; P Lacroix; R Roudaut; M Dallocchio
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

6.  Left ventricular hypertrophy regression during antihypertensive treatment.

Authors:  H Eichstaedt; O Danne; R J Schroeder; D Kreuz
Journal:  Clin Investig       Date:  1992

Review 7.  Does a reduction in left ventricular hypertrophy reduce cardiovascular morbidity and mortality?

Authors:  F H Messerli; F Soria
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 8.  Ventricular dysrhythmias, left ventricular hypertrophy, and sudden death.

Authors:  F H Messerli; F Soria
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

Review 9.  Left ventricular hypertrophy and antihypertensive therapy.

Authors:  F H Messerli; S Oren; E Grossman
Journal:  Drugs       Date:  1988       Impact factor: 9.546

10.  Once daily indapamide in the treatment of the elderly and young hypertensive.

Authors:  D B Rowlands; D R Glover; M A Young; T J Stallard; W A Littler
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.